Cantor Fitzgerald Maintains Overweight on InflaRx, Raises Price Target to $4
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Cantor Fitzgerald analyst Steve Seedhouse maintains InflaRx (NASDAQ:IFRX) with a Overweight and raises the price target from $2 to $4.
Cantor Fitzgerald analyst Steve Seedhouse maintains InflaRx (NASDAQ:IFRX) with a Overweight and raises the price target from $2 to $4.